Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "carcinomas" Harboring RAS Mutations

Thyroid

Volumn 27, Issue 4, 2017, Pages 506-511

  Paulson, Vera A ^a   Shivdasani, Priyanka ^a   Angell, Trevor E ^a   Cibas, Edmund S ^a   Krane, Jeffrey F ^a   Lindeman, Neal I ^a   Alexander, Erik K ^a   Barletta, Justine A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fine needle aspiration; follicular variant of papillary thyroid carcinoma; molecular testing; NIFTP; RAS; thyroid

Indexed keywords

H RAS PROTEIN; K RAS PROTEIN; PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE; HRAS PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MEMBRANE PROTEIN; NRAS PROTEIN, HUMAN; PROTEIN P21;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; FEMALE; GENE MUTATION; HUMAN; LOBECTOMY; MALE; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; ADENOCARCINOMA; FINE NEEDLE ASPIRATION BIOPSY; GENETICS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; TUMOR INVASION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; FEMALE; GTP PHOSPHOHYDROLASES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS P21(RAS); THYROID NEOPLASMS;

EID: 85017109125     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0583     Document Type: Article

References (34)

1. Hyeon J, Ahn S, Shin JH, Oh YL 2014 The prediction of malignant risk in the category ''atypia of undetermined significance/follicular lesion of undetermined significance'' of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results. Cancer Cytopathol 122:368-376
2. Kiernan CM, Broome JT, Solorzano CC 2014 The Bethesda System for Reporting Thyroid Cytopathology: A single-center experience over 5 years. Ann Surg Oncol 21: 3522-3527
3. Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ 3rd, Ganly I, Hodak SP, Kebebew E, Patel KN, Shaha A, Steward DL, Tufano RP, Wiseman SM, Carty SE; American Thyroid Association Surgical Affairs Committee 2015 American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making. Thyroid 25: 760-768
4. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New Engl J Med 367:705-715
5. Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN 2014 Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120:3627-3634
6. Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN 2015 Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid 25:1217-1223
7. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, Giordano TJ, Alves VA, Khanafshar E, Asa SL, El-Naggar AK, Gooding WE, Hodak SP, Lloyd RV, Maytal G, Mete O, Nikiforova MN, Nose V, Papotti M, Poller DN, Sadow PM, Tischler AS, Tuttle RM, Wall KB, LiVolsi VA, Randolph GW, Ghossein RA 2016 Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: A paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023-1029
8. Hodak S, Tuttle RM, Maytal G, Nikiforov YE, Randolph G 2016 Changing the cancer diagnosis: the case of follicular variant of papillary thyroid cancer-primum non nocere and NIFTP. Thyroid 26:869-871
9. Thompson LD 2016 Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod Pathol 29:698-707
10. Poller DN, Nikiforov YE 2016 Non-invasive follicular thyroid neoplasm with papillary-like nuclei: reducing overtreatment by reclassifying an indolent variant of papillary thyroid cancer. J Clin Pathol 2016 Jul 7. DOI: 10.1136/jclinpath-2016-203930 [Epub ahead of print]
11. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA 2006 Follicular variant of papillary thyroid carcinoma: A clinicopathologic study of a problematic entity. Cancer 107:1255-1264
12. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA 2010 Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23:1191-1200
13. Vivero M, Kraft S, Barletta JA 2013 Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid 23:273-279
14. Afkhami M, Karunamurthy A, Chiosea S, Nikiforova MN, Seethala R, Nikiforov YE, Coyne C 2016 Histopathologic and clinical characterization of thyroid tumors carrying the BRAF(K601E) mutation. Thyroid 26:242-247
15. Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, Pusztaszeri MP, VandenBussche CJ, Gourmaud J, Vaickus LJ, Baloch ZW 2016 Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 124:181-187
16. Howitt BE, Chang S, Eszlinger M, Paschke R, Drage MG, Krane JF, Barletta JA 2015 Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 144:850-857
17. Maletta F, Massa F, Torregrossa L, Duregon E, Casadei GP, Basolo F, Tallini G, Volante M, Nikiforov YE, Papotti M 2016 Cytological features of ''noninvasive follicular thyroid neoplasm with papillary-like nuclear features'' and their correlation with tumor histology. Hum Pathol 54: 134-142
18. Strickland KC, Howitt BE, Marqusee E, Alexander EK, Cibas ES, Krane JF, Barletta JA 2015 The impact of noninvasive follicular variant of papillary thyroid carcinoma on rates of malignancy for fine-needle aspiration diagnostic categories. Thyroid 25:987-992
19. Griffin GK, Sholl LM, Lindeman NI, Fletcher CD, Hornick JL 2016 Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NFkappaB regulatory genes. Mod Pathol 29:67-74
20. Mirkovic J, Sholl LM, Garcia E, Lindeman N, MacConaill L, Hirsch M, Dal Cin P, Gorman M, Barletta JA, Nucci MR, McCluggage WG, Howitt BE 2015 Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol 28:1504-1514
21. Sholl LM, Do K, Shivdasani P, Cerami E, Dubuc AM, Kuo FC, Garcia EP, Jia Y, Davineni P, Abo RP, Pugh TJ, van Hummelen P, Thorner AR, Ducar M, Berger AH, Nishino M, Janeway KA, Church A, Harris M, Ritterhouse LL, Campbell JD, Rojas-Rudilla V, Ligon AH, Ramkissoon S, Cleary JM, Matulonis U, Oxnard GR, Chao R, Tassell V, Christensen J, Hahn WC, Kantoff PW, Kwiatkowski DJ, Johnson BE, Meyerson M, Garraway LA, Shapiro GI, Rollins BJ, Lindeman NI, MacConaill LE 2016 Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight 1:e87062
22. Cibas ES, Ali SZ 2009 The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 132:658-665
23. Eszlinger M, Krogdahl A, Munz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bosenberg E, Drieschner N, Scholz M, Hegedus L, Paschke R 2014 Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid 24:305-313
24. Eszlinger M, Piana S, Moll A, Bosenberg E, Bisagni A, Ciarrocchi A, Ragazzi M, Paschke R 2015 Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas. Thyroid 25:401-409
25. Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK 2015 The variable phenotype and low-risk nature of RAS-positive thyroid nodules. BMC Med 13:184
26. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390-3397
27. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE 2010 Contribution of molecular testing to thyroid fine-needle aspiration cytology of ''follicular lesion of undetermined significance/atypia of undetermined significance.'' Cancer Cytopathol 118:17-23
28. Xu B, Ghossein R 2016 Genomic landscape of poorly differentiated and anaplastic thyroid carcinoma. Endocr Pathol 27:205-212
29. Nikiforov YE 2016 Ramifications of new terminology for encapsulated follicular variant of papillary thyroid carcinoma-reply. JAMA Oncol 2:1098-1099
30. Wong KS, Angell TE, Strickland KC, Alexander EK, Cibas ES, Krane JF, Barletta JA 2016 Noninvasive follicular variant of papillary thyroid carcinoma and the Afirma geneexpression classifier. Thyroid 26:911-915
31. Liu X, Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Larsen PR, Cho NL, Nehs MA, Ruan DT, Gawande A, Moore F Jr, Barletta J, Krane JF, Cibas ES, Yang T, Alexander EK 2016 Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis. Thyroid 26:256-261
32. VanderLaan PA, Marqusee E, Krane JF 2012 Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 120:245-253
33. Strickland KC, Vivero M, Jo VY, Lowe AC, Hollowell M, Qian X, Wieczorek TJ, French CA, Teot LA, Sadow PM, Alexander EK, Cibas ES, Barletta JA, Krane JF 2016 Preoperative cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: A prospective analysis. Thyroid 26:1466-1471
34. Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE 2014 PAX8/PPARgamma rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid 24:1369-1374.